Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2438]

New UK approach to prostate cancer screening needed

New UK approach to prostate cancer screening needed

More intensive radiotherapy is better than less for localised prostate cancer

More intensive radiotherapy is better than less for localised prostate cancer

Genetic screening can identify men with advanced prostate cancer

Genetic screening can identify men with advanced prostate cancer

Study reveals potential route to bladder cancer diagnostics, treatments

Study reveals potential route to bladder cancer diagnostics, treatments

Proton therapy for prostate cancer results in long-term patient survival and excellent quality of life

Proton therapy for prostate cancer results in long-term patient survival and excellent quality of life

Reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease with degarelix compared to LHRH agonists

Reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease with degarelix...

Molecular characterisation of urothelial bladder carcinoma

Molecular characterisation of urothelial bladder carcinoma

ASCO GU: Common drug improves survival in hypertensive patients with metastatic renal cell carcinoma

ASCO GU: Common drug improves survival in hypertensive patients with metastatic renal cell carcinoma

ASCO GU: Long-term data confirms radiotherapy plus anti-androgen therapy substantially improves 10- and 15-year prostate cancer survival rates

ASCO GU: Long-term data confirms radiotherapy plus anti-androgen therapy substantially improves 10- and 15-year...

ASCO GU: Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

ASCO GU: Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

More from ecancer